Levonorgestrel-Releasing Intrauterine System Articles

Bayer outperforms expectations for 2009, but 4th quarter and guidance disappoints

1 March 2010

US FDA warns four drugmakers on inaccurate promotion

13 January 2010

Bayer profit down 63% on restructuring and acquisition charges, despite higher sales

9 March 2009

Bayer's 2nd-qtr 2008 net profit falls 13%

11 August 2008

Bayer's 1st-qtr net profit reaches $1.21B, HealthCare unit bolsterd by drug sales

5 May 2008

Bayer's 4th-qtr 2007 profit plummets 76% to 67M euros, well below analyst expectations

10 March 2008

Bayer beats forecasts, helped by a tax gain, and leads markets higher

12 November 2007

Bayer Healthcare gets big boost from Schering as 2nd-qtr net leaps 46%

13 August 2007

UPDATE: Cancer drugs, OCs and Schering boost Bayer's 2nd-qtr, as group net leaps 46%

13 August 2007

Bayer Schering's Mirena cleared in Japan

12 February 2007

Takeover costs impact Schering AG's 1st-half 2006

31 July 2006

Takeover costs impact Schering's 1st-half 2006

26 July 2006

Germany's Schering AG sees 1st-qtr 2006 net sales growth of 16% to 1.41 billion euros

1 May 2006

Schering AG sees 2005 net leap 23%

27 February 2006

Schering AG sees 1st-qtr net profit rise 11%, with strong sales growth in USA

25 April 2005

Schering AG says it has set course for growth with good 2004 results

14 March 2005

Weak $ takes its toll on Schering AG's 4th-qtr sales, but profit rises 23%

14 February 2005

Schering AG raises 2004 forecast on 2nd-qtr

2 August 2004

Schering AG in LDC contraceptive access initiative

10 May 2004

Schering AG's 1st-qtr beats expectations

3 May 2004

UPDATE: Schering AG reports 6% "organic" sales growth for 2003, but conservative outlook

16 February 2004

Schering AG sees strong profit growth

3 November 2003

Profits and sales down at Schering AG

11 August 2003

Schering AG beats forecasts in 2002

10 March 2003

Update: Sales up 11% at Schering AG

10 March 2003

Schering AG's 2002 sales disappoint

10 February 2003

Schering AG US sales up 22% in Q2

5 August 2002

Schering AG CEO optimistic about firm's future prospects

22 April 2002

Leiras Oy offers technology for drug delivery

15 April 2002

Germany's Schering AG outlines prospects for future growth

11 March 2002

Net income up 24% at Schering AG as Betaferon sales stay strong

11 February 2002

Net income up 23% at Schering AG as Betaferon sales stay strong

9 November 2001

Strong double-digit rises in 2000 net income and sales for Schering AG

7 February 2001

Schering's Mirena cleared in USA

7 December 2000

Schering AG sales increase 25% in first three months of 2000

2 May 2000

Schering AG earnings jump 11% for 1999, possible flotation of biotech

21 March 2000

1999 sales and profits up at Schering AG - updated story

10 February 2000

Schering AG sales up 9% for 1st nine months

11 November 1999

Schering sales growth driven by Betaferon

11 August 1999

Schering sales growth driven by Betaferon

6 August 1999

Schering AG looking to list in the USA

4 May 1999

Europe/US sales offset Asian crisis at Schering

9 February 1999

Schering AG Profits Impacted By Asian Crisis

10 August 1998

Strong Start To 1998 By Schering AG

5 May 1998

Dutch Government Reimbursement Blacklist Rises To 35

9 December 1996

Schering AG To Buy Huhtamaki's Leiras Unit

22 July 1996

UK Industry Code of Practice: latest Report

4 March 1996

Profits Lower Than Expected At Huhtamaki

16 October 1995

Janssen Cilag has launched Retinova, a treatment for photodamaged skin

22 May 1995

Showing 1-49 of 49 articles

Go to beginningPrevious
  • 1
NextGo to end